1. Home
  2. Team
  3. Chris Murray

Chris joined MVM in 2024.  Prior to MVM, he was a manager at Bain & Company where he advised payor, provider, and healthcare IT clients on strategy and diligenced a broad range of healthcare assets for private equity firms. 

Before consulting, Chris trained in emergency medicine at Mass General Brigham.  He received his MD from Harvard Medical School and MBA from Harvard Business School.  Chris also holds a BA magna cum laude in global affairs from Yale.

Latest news

Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study
June 4, 2024
GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
April 15, 2024
Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024
GT Medical Technologies Names Per Langoe As CEO
February 20, 2024
MVM invests in icotec
January 24, 2024
MVM invests in Gynesonics
November 1, 2023
SkyCell Featured in TechCrunch
October 31, 2023
MVM invests in BioProtect
September 27, 2023
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
July 18, 2023
MVM invests in CurvaFix
July 14, 2023
View all